Turn Therapeutics (TTRX) Shares Outstanding (Weighted Average) (2024 - 2026)

Turn Therapeutics' Shares Outstanding (Weighted Average) history runs 3 years deep, the most recent figure standing at $29.5 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 9.35% year-over-year to $29.5 million; the TTM figure through Mar 2026 stood at $29.5 million (up 9.35% YoY), while the FY2025 annual figure was $27.7 million, up 4.03% from the prior year.
• Shares Outstanding (Weighted Average) was $29.5 million for Q1 2026 at Turn Therapeutics, up from $27.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $29.5 million in Q1 2026 to a low of $26.6 million in Q4 2024.
• Historically, Shares Outstanding (Weighted Average) has averaged $27.6 million across 3 years, with a median of $27.3 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Weighted Average) advanced 4.03% in 2025, then climbed 9.35% in 2026.
• A 3-year view of Shares Outstanding (Weighted Average) shows it stood at $26.6 million in 2024, then advanced by 4.03% to $27.7 million in 2025, then rose by 6.35% to $29.5 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $29.5 million (Q1 2026), $27.7 million (Q4 2025), and $28.0 million (Q3 2025), per Business Quant data.